Matthew Burke, Oncology/Hematology Nurse Practitioner. Director, Principal Scientist at MSD, shared a post on LinkedIn:
“This week has been another busy one for the Trial Engagement and Site Partnership Team at MSD.
Our primary focus was on metastatic triple negative breast cancer, collaborating with investigators from across Europe.
Together, we are advancing our science and striving to help patients affected by this aggressive form of cancer.”
Other articles featuring Matthew Burke on OncoDaily.